Notably, in the Munich General Practitioner Project [22] and in the ARIC study [23], increased levels of VWF:ag were identified as risk factors for macrovascular prevalence and mortality in type 2 diabetes. The gene discussed is VWF; the disease is type 2 diabetes mellitus.